Pms-amitriptyline 10 Mg, 25 Mg, And 50 Mg: Ndma And Nnort Impurity
Recall Summary PMS-AMITRIPTYLINE tablets in 10 mg, 25 mg, and 50 mg strengths are being recalled across Canada because they contain higher-than-acceptable levels of NDMA and NNORT impurities. This is a Class I recall, indicating a serious safety concern. The affected medication was distributed throughout Canada.
- Product
- PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg
- Reason
- Contamination
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-08-16
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9a1ce0e1-c89b-44a8-be7f-9926963ac673